Journal Publications

Export 124 results:
Author Title [ Type(Desc)] Year
Filters: Type is Journal Article  [Clear All Filters]
Journal Article
Late diagnosis in the HAART era: proposed common definitions and associations with mortality. Sabin C, Schwenk A, Johnson M, Gazzard B, Fisher M, Walsh J, Orkin C, Hill T, Gilson R, Porter K et al. AIDS, 2010 Mar 13, Volume 24, Issue 5, p.723-7, (2010)
Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Mocroft A, Lundgren J, Antinori A, Monforte A, Brännström J, Bonnet F, Brockmeyer N, Casabona J, Castagna A, Costagliola D et al. Euro Surveill, 2015, Volume 20, Issue 47, (2015)
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. Phillips A, Dunn D, Sabin C, Pozniak A, Matthias R, Geretti A, Clarke J, Churchill D, Williams I, Hill T et al. AIDS, 2005 Mar 25, Volume 19, Issue 5, p.487-94, (2005)
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery. Engsig F, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G et al. Clin Infect Dis, 2014 May, Volume 58, Issue 9, p.1312-21, (2014)
Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy. . Clin Infect Dis, 2010 May 01, Volume 50, Issue 9, p.1275-85, (2010)
Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study. Hughes R, Sterne J, Walsh J, Bansi L, Gilson R, Orkin C, Hill T, Ainsworth J, Anderson J, Gompels M et al. HIV Med, 2011 Nov, Volume 12, Issue 10, p.583-93, (2011)
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study. Dolling D, Dunn D, Sutherland K, Pillay D, Mbisa J, Parry C, Post F, Sabin C and Cane P. J Antimicrob Chemother, 2013 Oct, Volume 68, Issue 10, p.2339-43, (2013)
Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis. . AIDS, 2016 Jan 28, Volume 30, Issue 3, p.503-13, (2016)
No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom. White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin C, Pillay D and Dunn D. J Infect Dis, 2016 Nov 01, Volume 214, Issue 9, p.1302-1308, (2016)
Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UK. Kober C, Johnson M, Fisher M, Hill T, Anderson J, Bansi L, Gompels M, Palfreeman A, Dunn D, Gazzard B et al. HIV Med, 2012 Jan, Volume 13, Issue 1, p.73-8, (2012)
Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study. Barber T, Geretti A, Anderson J, Schwenk A, Phillips A, Bansi L, Gilson R, Hill T, Walsh J, Fisher M et al. Antivir Ther, 2011, Volume 16, Issue 6, p.805-14, (2011)
Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UK. Easterbrook P, Phillips A, Hill T, Matthias R, Fisher M, Gazzard B, Gilson R, Scullard G, Johnson M, Dunn D et al. HIV Med, 2008 Jan, Volume 9, Issue 1, p.47-56, (2008)
A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK. Mourad R, Chevennet F, Dunn D, Fearnhill E, Delpech V, Asboe D, Gascuel O and Hue S. AIDS, 2015 Sep 24, Volume 29, Issue 15, p.1917-25, (2015)
Population trends in the prevalence and patterns of protease resistance related to exposure to unboosted and boosted protease inhibitors. Dunn D, Geretti A, Green H, Fearnhill E, Pozniak A, Churchill D, Pillay D, Sabin C and Phillips A. Antivir Ther, 2008, Volume 13, Issue 6, p.771-7, (2008)
Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data. Price H, Asboe D, Pozniak A, Gazzard B, Fearnhill E, Pillay D and Dunn D. Antivir Ther, 2010, Volume 15, Issue 2, p.203-11, (2010)
Predicting virological decay in patients starting combination antiretroviral therapy. . AIDS, 2016 Jul 17, Volume 30, Issue 11, p.1817-27, (2016)
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes. Costagliola D, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, De Luca A, Jansen K et al. J Infect Dis, 2013 Mar 01, Volume 207, Issue 5, p.759-67, (2013)
Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care. Huntington S, Thorne C, Bansi L, Anderson J, Newell M, Taylor G, Pillay D, Hill T, Tookey P and Sabin C. AIDS, 2013 Jan 02, Volume 27, Issue 1, p.95-103, (2013)
Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy. Huntington S, Thorne C, Newell M, Anderson J, Taylor G, Pillay D, Hill T, Tookey P and Sabin C. AIDS, 2015 Apr 24, Volume 29, Issue 7, p.801-9, (2015)
The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomes. Turner J, Bansi L, Gilson R, Gazzard B, Walsh J, Pillay D, Orkin C, Phillips A, Easterbrook P, Johnson M et al. J Viral Hepat, 2010 Aug, Volume 17, Issue 8, p.569-77, (2010)
Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy. Bohlius J, Schmidlin K, Costagliola D, Fätkenheuer G, May M, Murillo A, Mocroft A, Bonnet F, Clifford G, Touloumi G et al. AIDS, 2009 Sep 24, Volume 23, Issue 15, p.2029-37, (2009)
Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count. Phillips A, Gazzard B, Gilson R, Easterbrook P, Johnson M, Walsh J, Leen C, Fisher M, Orkin C, Anderson J et al. AIDS, 2007 Aug 20, Volume 21, Issue 13, p.1717-21, (2007)
The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study. Smith C, Phillips A, Hill T, Fisher M, Gazzard B, Porter K, Gilson R, Easterbrook P, Matthias R, Scullard G et al. J Infect Dis, 2005 Oct 15, Volume 192, Issue 8, p.1387-97, (2005)
REACH: a mixed-methods study to investigate the measurement, prediction and improvement of retention and engagement in outpatient HIV care. Howarth A, Apea V, Michie S, Morris S, Sachikonye M, Mercer C, Evans A, Delpech V, Sabin C and Burns F. Health Services and Delivery Research, Volume 5, Issue 13, (2017)
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients. Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, Monforte A, Mary-Krause M, Roca B, Miro J et al. HIV Med, 2017 Jan, Volume 18, Issue 1, p.33-44, (2017)